Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis

Endoscopy

Volumn 34, Issue 11, 2002, Pages 909-916

  Lindberg, B ^a   Arnelo, U ^a   Bergquist, A ^a   Thorne A ^a   Hjerpe, A ^a   Granqvist, S ^b   Hansson, L O ^a   Tribukait, B ^a   Persson, B ^a   Broome U ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE LEVEL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMAN; INTESTINE BRUSH BORDER; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT NEOPLASMS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; CYTODIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLOIDIES; SENSITIVITY AND SPECIFICITY;

EID: 18744365840     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35298     Document Type: Article

References (33)

1. MacCarty RL et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances. Radiology 1985; 156: 43 - 46
2. Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 26 - 30
3. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 1985; 102: 581-587
4. Lammer J et al. Pseudotumorous pancreatitis. Gastrointest Radiol 1985; 10: 59 - 67
5. Verbeek PC et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112: 866 - 871
6. Ferrari AP Jr. et al. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endoscopy 1994; 40: 140 - 145
7. Ryan ME. Cytological brushings of ductal lesions during ERCP. Gastrointest Endoscopy 1991; 37: 139 - 142
8. Rabinovitz M et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology 1990; 12: 747 - 752
9. Ponsioen CY et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999; 31: 305 - 309
10. Bergquist A et al. Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J Hepatol 2000; 33: 873 - 877
11. Ryan ME, Baldauf MC. Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures. Gastrointest Endoscopy 1994; 40: 133 - 139
12. Sears RJ et al. Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography. Cancer 1998; 84: 119 - 126
13. Rumalla A et al. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc 2001; 76: 29 - 33
14. Ramage JK et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865 - 869
15. Nakeeb A et al. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma (discussion 152 - 153). American Journal of Surgery 1996; 171: 147 - 152
16. Bjornsson E, Kilander A, Olsson R. CA19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999; 19: 501 - 508
17. Hultcrantz R et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999; 30: 669 - 673
18. Nichols JC et al. Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clinic Proc 1993; 68: 874-879
19. Chapman RW et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870-877
20. Castro J et al. Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 1993; 14: 793-804
21. Chalasani N et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000; 31: 7-11
22. Ker CG et al. Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma. J Gastroenterol Hepatol 1991; 6: 505-508
23. Bergquist A et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998; 27: 311-316
24. Löfberg R et al. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990; 99: 1021-1031
25. Gyde SN et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988; 29: 206-217
26. Rosenstock E et al. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985; 89: 1342-1346
27. Buffet C et al. Bile levels of carcino-embryonic antigen in patients with hepatopancreatobiliary disease. Eur J Gastroenterol Hepatol 1996; 8: 131-134
28. Ohshio G et al. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice. Am J Gastroenterol 1990; 85: 1370-1376
29. Jailwala J et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endoscopy 2000; 51: 383-390
30. Gross JA et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997; 225: 472-481
31. de Groen PC et al. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378
32. Johlin FCVM, Wut YM. Surveillance cytology (SC) in detection of asymptomatic progression to cholangiocarcinoma (CCC) in patients with primary sclerosing cholangitis. Hepatology 1998; 28 (Suppl.): 393A
33. Keiding S et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28: 700-706